• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子 1α 在肝缺血再灌注损伤中促进白细胞介素-1 受体拮抗剂的表达。

Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury.

机构信息

Tianjin Key Laboratory of Tumor Microenvironment and Neurovascular Regulation, Medical College of Nankai University, Tianjin 300071, China.

Department of Internal Medicine, Wangdingdi Hospital, Tianjin 300071, China.

出版信息

World J Gastroenterol. 2022 Oct 14;28(38):5573-5588. doi: 10.3748/wjg.v28.i38.5573.

DOI:10.3748/wjg.v28.i38.5573
PMID:36304082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9594012/
Abstract

BACKGROUND

Ischemia-reperfusion injury (IRI) is a major risk associated with liver surgery and transplantation, and its pathological mechanism is complex. Interleukin-1 receptor antagonist (IL-1ra) can protect the liver from IRI. However, the regulatory mechanism of IL-1ra expression is still unclear.

AIM

To identify the mechanism that could protect the liver in the early stage of IRI.

METHODS

To screen the key genes in hepatic IRI, we performed RNA sequencing and gene enrichment analysis on liver tissue from mice with hepatic IRI. Subsequently, we verified the expression and effect of IL-1ra in hepatic IRI. We also used promoter mutagenesis and chromatin immunoprecipitation assay to search for the transcriptional regulatory sites of hypoxia-inducible factor (HIF)-1α. Finally, to explore the protective mechanism of ischemic preconditioning (IP), we examined the expression of HIF-1α and IL-1ra after IP.

RESULTS

We identified IL-1ra as a key regulator in hepatic IRI. The expression of IL-1ra was significantly upregulated after hepatic IRI both and . Furthermore, we found that HIF-1α regulated transcription in response to hypoxia. Increased HIF-1α accumulation promoted IL-1ra expression, whereas inhibition of HIF-1α exhibited the opposite effect. We also confirmed a predominant role for hypoxia response element in the regulation of transcription by HIF-1α activation. Of note, we demonstrated that IP protects against hepatic IRI by inducing IL-1ra expression, which is mediated through HIF-1α.

CONCLUSION

We demonstrated that ischemia or hypoxia leads to increased expression of IL-1ra through HIF-1α. Importantly, IP protects the liver from IRI the HIF-1α-IL-1ra pathway.

摘要

背景

缺血再灌注损伤(IRI)是与肝外科和肝移植相关的主要风险因素,其病理机制复杂。白介素-1 受体拮抗剂(IL-1ra)可保护肝脏免受 IRI 损伤。然而,IL-1ra 表达的调控机制尚不清楚。

目的

确定在 IRI 早期阶段可保护肝脏的机制。

方法

为筛选肝 IRI 中的关键基因,我们对肝 IRI 小鼠的肝组织进行了 RNA 测序和基因富集分析。随后,我们验证了 IL-1ra 在肝 IRI 中的表达和作用。我们还使用启动子诱变和染色质免疫沉淀实验来寻找缺氧诱导因子(HIF)-1α的转录调控位点。最后,为探讨缺血预处理(IP)的保护机制,我们检测了 IP 后 HIF-1α 和 IL-1ra 的表达。

结果

我们发现 IL-1ra 是肝 IRI 的关键调节因子。肝 IRI 后 和 时,IL-1ra 的表达均显著上调。此外,我们发现 HIF-1α 可在缺氧时调节 的转录。HIF-1α 积累增加可促进 IL-1ra 表达,而抑制 HIF-1α 则呈现相反效果。我们还证实,缺氧反应元件在 HIF-1α 激活调控 的转录中起主要作用。值得注意的是,我们证实 IP 通过诱导 IL-1ra 表达来保护肝脏免受 IRI 损伤,而 IL-1ra 的表达是通过 HIF-1α 介导的。

结论

我们证明,缺血或缺氧会通过 HIF-1α 导致 IL-1ra 的表达增加。重要的是,IP 通过 HIF-1α-IL-1ra 通路来保护肝脏免受 IRI。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/77f2280a7d74/WJG-28-5573-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/3dd86e8ee7ef/WJG-28-5573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/5bd9f8b53b54/WJG-28-5573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/85c4477e3b1b/WJG-28-5573-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/0b46bf05689f/WJG-28-5573-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/0b271605f388/WJG-28-5573-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/b5528650c90c/WJG-28-5573-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/57bf54faab31/WJG-28-5573-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/77f2280a7d74/WJG-28-5573-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/3dd86e8ee7ef/WJG-28-5573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/5bd9f8b53b54/WJG-28-5573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/85c4477e3b1b/WJG-28-5573-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/0b46bf05689f/WJG-28-5573-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/0b271605f388/WJG-28-5573-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/b5528650c90c/WJG-28-5573-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/57bf54faab31/WJG-28-5573-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e950/9594012/77f2280a7d74/WJG-28-5573-g008.jpg

相似文献

1
Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury.缺氧诱导因子 1α 在肝缺血再灌注损伤中促进白细胞介素-1 受体拮抗剂的表达。
World J Gastroenterol. 2022 Oct 14;28(38):5573-5588. doi: 10.3748/wjg.v28.i38.5573.
2
Hypoxia-inducible factor-1alpha protects the liver against ischemia-reperfusion injury by regulating the A2B adenosine receptor.缺氧诱导因子-1α通过调节A2B腺苷受体保护肝脏免受缺血再灌注损伤。
Bioengineered. 2021 Dec;12(1):3737-3752. doi: 10.1080/21655979.2021.1953217.
3
Involvement of the HIF-1α and Wnt/β-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury.HIF-1α 和 Wnt/β-catenin 通路参与氯沙坦对缺血/再灌注损伤脂肪性供肝的保护作用。
Clin Sci (Lond). 2014 Jan;126(2):163-74. doi: 10.1042/CS20130025.
4
Ischemic preconditioning-induced protective effect for promoting angiogenesis in renal ischemia-reperfusion injury by regulating miR-376c-3p/HIF-1α/VEGF axis in male rats.缺血预处理通过调节雄性大鼠肾缺血再灌注损伤中的miR-376c-3p/HIF-1α/VEGF轴对促进血管生成的保护作用。
Life Sci. 2022 Jun 15;299:120357. doi: 10.1016/j.lfs.2022.120357. Epub 2022 Jan 29.
5
Systematic review with meta-analysis: HIF-1α attenuates liver ischemia-reperfusion injury.系统评价与荟萃分析:缺氧诱导因子-1α减轻肝脏缺血再灌注损伤。
Transplant Rev (Orlando). 2015 Jul;29(3):127-34. doi: 10.1016/j.trre.2015.05.001. Epub 2015 May 7.
6
miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.在延迟性缺血预处理中,微小RNA-21通过靶向脯氨酰羟化酶结构域蛋白2发挥肾脏保护作用。
Nephrology (Carlton). 2017 May;22(5):366-373. doi: 10.1111/nep.12787.
7
p53 regulates renal expression of HIF-1{alpha} and pVHL under physiological conditions and after ischemia-reperfusion injury.在生理条件下以及缺血再灌注损伤后,p53调节缺氧诱导因子-1α(HIF-1α)和泛素蛋白连接酶E3(pVHL)在肾脏中的表达。
Am J Physiol Renal Physiol. 2008 Dec;295(6):F1666-77. doi: 10.1152/ajprenal.90304.2008. Epub 2008 Sep 24.
8
Fatty acid binding protein-4 (FABP4) is a hypoxia inducible gene that sensitizes mice to liver ischemia/reperfusion injury.脂肪酸结合蛋白4(FABP4)是一种缺氧诱导基因,可使小鼠对肝脏缺血/再灌注损伤敏感。
J Hepatol. 2015 Oct;63(4):855-62. doi: 10.1016/j.jhep.2015.05.030. Epub 2015 Jun 10.
9
Expression of constitutively stable hybrid hypoxia-inducible factor-1alpha protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury.组成型稳定杂交缺氧诱导因子-1α的表达可保护培养的大鼠心肌细胞免受模拟缺血再灌注损伤。
Am J Physiol Cell Physiol. 2005 Feb;288(2):C314-20. doi: 10.1152/ajpcell.00374.2004. Epub 2004 Oct 20.
10
Activation of TGR5 restores AQP2 expression via the HIF pathway in renal ischemia-reperfusion injury.TGR5 的激活通过 HIF 通路在肾缺血再灌注损伤中恢复 AQP2 的表达。
Am J Physiol Renal Physiol. 2021 Mar 1;320(3):F308-F321. doi: 10.1152/ajprenal.00577.2020. Epub 2021 Jan 11.

引用本文的文献

1
Role of Ischemia/Reperfusion and Oxidative Stress in Shock State.缺血/再灌注及氧化应激在休克状态中的作用
Cells. 2025 May 30;14(11):808. doi: 10.3390/cells14110808.
2
Dexmedetomidine Blocks the ERK Pathway by Inhibiting MAP3K8 to Achieve a Protective Effect in Lung Ischemia/Reperfusion Injury.右美托咪定通过抑制丝裂原活化蛋白激酶激酶激酶8阻断细胞外信号调节激酶通路,从而在肺缺血/再灌注损伤中发挥保护作用。
Kaohsiung J Med Sci. 2025 Sep;41(9):e70045. doi: 10.1002/kjm2.70045. Epub 2025 May 15.
3
Mesenchymal stem cell-derived exosomes: an emerging therapeutic strategy for hepatic ischemia-reperfusion injury.

本文引用的文献

1
Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment.用于治疗缺血再灌注损伤的槲皮素脂质体纳米制剂
Pharmaceutics. 2022 Jan 3;14(1):104. doi: 10.3390/pharmaceutics14010104.
2
Ischemia/Reperfusion Injury of Fatty Liver Is Protected by A2AR and Exacerbated by A1R Stimulation through Opposite Effects on ASK1 Activation.肝脂肪变性的缺血/再灌注损伤通过 A2AR 保护和 A1R 刺激通过对 ASK1 激活的相反作用而加剧。
Cells. 2021 Nov 15;10(11):3171. doi: 10.3390/cells10113171.
3
Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1.
间充质干细胞衍生外泌体:一种用于肝缺血再灌注损伤的新兴治疗策略。
Stem Cell Res Ther. 2025 Apr 14;16(1):178. doi: 10.1186/s13287-025-04302-9.
4
Current understanding on inferior quality of liver grafts by donation after circulatory death based on multi-omics data.基于多组学数据对心脏死亡后捐献肝脏移植物质量欠佳的当前认识。
Front Immunol. 2025 Mar 20;16:1548735. doi: 10.3389/fimmu.2025.1548735. eCollection 2025.
5
MAFF alleviates hepatic ischemia-reperfusion injury by regulating the CLCF1/STAT3 signaling pathway.MAFF通过调节CLCF1/STAT3信号通路减轻肝脏缺血再灌注损伤。
Cell Mol Biol Lett. 2025 Apr 1;30(1):39. doi: 10.1186/s11658-025-00721-x.
6
Hypoxic Inducible Factor Stabilization in Pericytes beyond Erythropoietin Production: The Good and the Bad.周细胞中缺氧诱导因子的稳定作用:除促红细胞生成素产生外的影响,利弊共存
Antioxidants (Basel). 2024 Apr 27;13(5):537. doi: 10.3390/antiox13050537.
7
Hypoxia, hypoxia-inducible factors and inflammatory bowel diseases.缺氧、缺氧诱导因子与炎症性肠病
Gastroenterol Rep (Oxf). 2024 Apr 17;12:goae030. doi: 10.1093/gastro/goae030. eCollection 2024.
锯齿状 1-Notch1 靶向的肿瘤血管周龛促进乳腺癌干细胞表型通过 Zeb1。
Nat Commun. 2020 Oct 12;11(1):5129. doi: 10.1038/s41467-020-18860-4.
4
The Role of HIF in Immunity and Inflammation.缺氧诱导因子在免疫与炎症中的作用。
Cell Metab. 2020 Oct 6;32(4):524-536. doi: 10.1016/j.cmet.2020.08.002. Epub 2020 Aug 26.
5
Chitosan protects liver against ischemia-reperfusion injury via regulating Bcl-2/Bax, TNF-α and TGF-β expression.壳聚糖通过调节 Bcl-2/Bax、TNF-α 和 TGF-β 的表达来保护肝脏免受缺血再灌注损伤。
Int J Biol Macromol. 2020 Dec 1;164:1565-1574. doi: 10.1016/j.ijbiomac.2020.07.212. Epub 2020 Jul 29.
6
Aging aggravated liver ischemia and reperfusion injury by promoting STING-mediated NLRP3 activation in macrophages.衰老通过促进巨噬细胞中 STING 介导的 NLRP3 激活加剧肝脏缺血再灌注损伤。
Aging Cell. 2020 Aug;19(8):e13186. doi: 10.1111/acel.13186. Epub 2020 Jul 14.
7
Protective role of -acetyl-l-tryptophan against hepatic ischemia-reperfusion injury via the RIP2/caspase-1/IL-1β signaling pathway.-乙酰基-L-色氨酸通过 RIP2/caspase-1/IL-1β 信号通路对肝缺血再灌注损伤的保护作用。
Pharm Biol. 2019 Dec;57(1):385-391. doi: 10.1080/13880209.2019.1617750.
8
Ischemic Preconditioning on Liver Ischemia Reperfusion Injury: How Far is the Bedside from the Bench?缺血预处理对肝脏缺血再灌注损伤的影响:临床与基础研究的距离有多远?
J Invest Surg. 2020 Oct;33(9):884-885. doi: 10.1080/08941939.2019.1578443. Epub 2019 Mar 19.
9
Burden of liver diseases in the world.世界范围内的肝脏疾病负担。
J Hepatol. 2019 Jan;70(1):151-171. doi: 10.1016/j.jhep.2018.09.014. Epub 2018 Sep 26.
10
Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.肝细胞特异性缺失 IL1-RI 通过阻断 IL-1 驱动的自身炎症来减轻肝损伤。
J Hepatol. 2018 May;68(5):986-995. doi: 10.1016/j.jhep.2018.01.008. Epub 2018 Jan 31.